AVIR Atea Pharmaceuticals, Inc.
Healthcare$4.53+2.49%ClosedMarket Cap: $362.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.50
P/S
0.00
EV/EBITDA
-1.48
DCF Value
$1.01
FCF Yield
-41.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-57.0%
ROA
-63.5%
ROIC
-78.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-48.0M | $-45.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-54.9M | $-44.9M | $— | — |
| FY null | $0.00 | NaN% | $-180.9M | $-158.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-45.6M | $-42.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-41.3M | $-37.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-39.0M | $-34.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-39.0M | $-33.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-192.9M | $-168.4M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-37.2M | $-31.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-46.9M | $-40.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-69.8M | $-63.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-46.6M | $-39.2M | $-0.47 | — |